Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 10Head and Neck Neoplasms 7Radiodermatitis 5Lymphedema 5Stomatitis 4Neoplasms 4Radiation Injuries 3Ulcer 2Mucositis 2Fibrosis 2Dermatitis 2Xerostomia 1Wounds and Injuries 1Trismus 1Squamous Cell Carcinoma of Head and Neck 1Skin Diseases 1Peripheral Nervous System Diseases 1Ovarian Neoplasms 1Eczema 1Breast Cancer Lymphedema 1

Interventions

binimetinib 2ipatasertib 1exemestane 1encorafenib 1baricitinib 1atezolizumab 1Vemurafenib 1VP-102 1Trabectedin 1Spironolactone 1Paclitaxel 1Low-Level Light Therapy 1Leuprolide 1Fluorouracil 1Everolimus 1Equipment and Supplies 1Dacarbazine 1Cetuximab 1Cantharidin 1BF-200 ALA 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Skin Diseases × Low-Level Light Therapy × Clear all
NCT03924011 2021-09-01

LABRA

Hasselt University

Phase NA Completed
71 enrolled
Breast

Breast Neoplasms, Neoplasms, Radiation Injuries, Radiodermatitis, Skin Diseases, Wounds and Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡